Glucose‐dependent insulinotropic polypeptide receptor antagonist treatment causes a reduction in weight gain in ovariectomised high fat diet‐fed mice

BACKGROUND AND PURPOSE: The incretin hormone, gastric inhibitory peptide/glucose‐dependent insulinotropic polypeptide (GIP), secreted by the enteroendocrine K‐cells in the proximal intestine, may regulate lipid metabolism and adiposity, but its exact role in these processes is unclear. EXPERIMENTAL...

Descripción completa

Detalles Bibliográficos
Autores principales: Boer, Geke Aline, Hunt, Jenna Elizabeth, Gabe, Maria Buur Nordskov, Windeløv, Johanne Agerlin, Sparre‐Ulrich, Alexander Hovard, Hartmann, Bolette, Holst, Jens Juul, Rosenkilde, Mette Marie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9544171/
https://www.ncbi.nlm.nih.gov/pubmed/35710141
http://dx.doi.org/10.1111/bph.15894

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9544171/
https://www.ncbi.nlm.nih.gov/pubmed/35710141
http://dx.doi.org/10.1111/bph.15894

Ejemplares similares